丁香园 | 丁香通 | 丁香人才 | 丁香会议  
 点击次数:

灭活疫苗(甲类流感病毒H5N1亚型)的安全性和免疫原性

转载请注明来自丁香园
发布日期:2009-01-22 14:21 文章来源:<a href='http://www.dxy.cn'>丁香园</a>
关键词: H5N1 灭活疫苗 安全   点击次数:

Title: Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine

Author(s): Treanor, JJ; Campbell, JD; Zangwill, KM, et al.

Source: NEW ENGLAND JOURNAL OF MEDICINE   Volume: 354   Issue: 13   Pages: 1343-1351   Published: MAR 30 2006
Times Cited: 139

BACKGROUND: Influenza A (H5N1) viruses could cause a severe worldwide epidemic, with high attack rates, large numbers of deaths and hospitalizations, and wide disruption. Effective vaccines against these viruses in humans are urgently needed. METHODS: We conducted a multicenter, double-blind two-stage study involving 451 healthy adults 18 to 64 years of age who were randomly assigned in a 2:2:2:2:1 ratio to receive two intramuscular doses of a subvirion influenza A (H5N1) vaccine of 90, 45, 15, or 7.5 microg of hemagglutinin antigen or placebo. The subjects were followed for the safety analysis for 56 days. Serum samples obtained before each vaccination and again 28 days after the second vaccination were tested for H5 antibody by microneutralization and hemagglutination inhibition. RESULTS: Mild pain at the injection site was the most common adverse event for all doses of vaccine. The frequency of a serum antibody response was highest among subjects receiving doses of 45 microg or 90 microg. Among those who received two doses of 90 microg, neutralization antibody titers reached 1:40 or greater in 54 percent, and hemagglutination-inhibition titers reached 1:40 or greater in 58 percent. Neutralization titers of 1:40 or greater were seen in 43 percent, 22 percent, and 9 percent of the subjects receiving two doses of 45, 15, and 7.5 microg, respectively. No responses were seen in placebo recipients. CONCLUSIONS: A two-dose regimen of 90 microg of subvirion influenza A (H5N1) vaccine does not cause severe side effects and, in the majority of recipients, generates neutralizing antibody responses typically associated with protection against influenza. A conventional subvirion H5 influenza vaccine may be effective in preventing influenza A (H5N1) disease in humans.

请点这里参加丁香园论坛讨论 >>

编辑: yang

以下网友留言只代表网友个人观点,不代表网站观点